acute myeloid leukemia, CEBPA gene mutation

Acute myeloid leukemia with a CEBPA gene mutation is a blood cancer where a change in the CEBPA gene is identified. This gene is important as it encodes a protein called CCAAT/enhancer binding protein alpha, which normally helps control blood cell growth and development. In this condition, the mutation is seen in cases where the chromosomes otherwise appear normal. People with this condition have a specific change in their CEBPA gene. Although more research is needed to fully understand how this mutation influences the disease, identifying it helps classify this subgroup of acute myeloid leukemia. Information not available on additional clinical details or wider impacts is noted in this summary.

Information about symptoms is currently limited for this condition.

This form of acute myeloid leukemia is linked to a mutation in the CEBPA gene. The mutation changes the protein involved in blood cell development, which can lead to the uncontrolled growth seen in leukemia. The mutation itself is the main genetic factor associated with this condition.

Information about treatment is currently limited for this condition.

Information about prognosis is currently limited for this condition.

Information about current research is currently limited for this condition.